Course Overview
Join Dr. Handberg to review novel lipid-lowering medications on the market today and examine the effect of social determinants of health on access and adherence to lipid-lowering medications. Patient Advocate Sheryl Zaworski shares a patient perspective of shared decision-making in access and adherence.
Member Cost: $0Non-member Cost: $0
Credits: 0.0 CE contact hours, 0.0 CE pharmacology hours
Learning Objectives
1. Review novel lipid-lowering medications on the market today
2. Examine the effect of social determinants of health on access and adherence to lipid-lowering medications
3. Explore a patient perspective of shared decision-making in access and adherence
Non-CE certificate of attendance/participation is available upon submission of the program evaluation.
Related Resources
- CE Course: Complex Cases in Lipid Management: Treating LDL and Beyond - 0.9 CE contact hours, 0.75 pharmacology
- CE Course: Non-Statin Therapies for Lipid Management - 0.75 CE contact hours, 0.75 pharmacology
- Cholesterol patient tools and handouts
Faculty
- Eileen Handberg, PhD, ARNP, BC, FAHA, FACC
- Patient Champion: Sheryl Zaworski
PCNA is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider number: 030602.